Roche, Jnana sign multi-target collaboration deal for small molecule drugs

This article was originally published here

According to Jnana Therapeutics, the small molecule drugs will be developed for targeting the solute carrier (SLC) family of metabolite transporters for regulating cellular metabolism. The Massachusetts-based biotech

The post Roche, Jnana sign multi-target collaboration deal for small molecule drugs appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply